DexCom, Inc.
DXCM Healthcare Medical Devices
DexCom, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.7 billion, up 15.6% from fiscal 2024. In the quarter to June 2026, revenue grew 13.1%, EPS grew 41.3%, free cash flow fell 11.7% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; revenue growth for ten consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.
Follow DXCM
DexCom, Inc. (DXCM) Current ratio
DexCom, Inc.'s current ratio at the end of the quarter to 30 June 2026 was 1.7×, down 0.1× from fiscal 2025 (1.9×). Over the past ten years it has ranged from 1.5× (fiscal 2024) to 7.6× (fiscal 2018); the current reading is higher than 18% of that period. That is below the Medical Devices industry median of 2.5× and below the Healthcare sector median of 3.0×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2025 | 1.9× | 28.31% |
| FY2024 | 1.5× | (48.42%) |
| FY2023 | 2.8× | 42.60% |
| FY2022 | 2.0× | (60.98%) |
| FY2021 | 5.1× | (8.35%) |
| FY2020 | 5.6× | 2.00% |
| FY2019 | 5.5× | (28.45%) |
| FY2018 | 7.6× | 42.53% |
| FY2017 | 5.4× | 96.07% |
| FY2016 | 2.7× | (20.91%) |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Jun 2026 | 1.7× | (11.02%) |
| Mar 2026 | 1.9× | 3.47% |
| Dec 2025 | 1.9× | 20.32% |
| Sep 2025 | 1.6× | 2.91% |
| 42 more quarters | Free account |
Against its own ten years
Current ratio against peers
| Company | Current ratio |
|---|---|
| PEN Penumbra, Inc. compare | 5.7× |
| EW Edwards Lifesciences Corporation compare | 4.5× |
| SNN Smith & Nephew SNATS, Inc. compare | 2.1× |
| STE STERIS plc compare | 1.9× |
| DXCM DexCom, Inc. | 1.7× |
| ZBH Zimmer Biomet Holdings, Inc. compare | 1.7× |
| GEHC GE HealthCare Technologies Inc. compare | 1.3× |
| PHG Koninklijke Philips N.V. compare | 1.3× |
| BSX Boston Scientific Corporation compare | 1.2× |
| Medical Devices industry median | 2.5× |
| Healthcare sector median | 3.0× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)
More on DXCM
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement